4//SEC Filing
Bhatia Sangeeta N. 4
Accession 0000875320-24-000117
CIK 0000875320other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:05 PM ET
Size
6.2 KB
Accession
0000875320-24-000117
Insider Transaction Report
Form 4
Bhatia Sangeeta N.
Director
Transactions
- Sale
Common Stock
2024-05-02$402.95/sh−467$188,178→ 4,435 total - Award
Common Stock
2024-05-01+1,001→ 4,902 total
Footnotes (2)
- [F1]Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
- [F2]Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/10/2023.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001643921
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:05 PM ET
- Size
- 6.2 KB